A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
Clinical trial NCT04535037 · COMPLETED
Trial details
- NCT number
- NCT04535037
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-26
- Primary completion
- 2022-07-25
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.